Incivek and Ascites - a phase IV clinical study of FDA data

Summary:

Ascites is reported as a side effect among people who take Incivek (telaprevir), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Ribavirin, and have High blood pressure.

The phase IV clinical study analyzes which people have Ascites when taking Incivek. It is created by eHealthMe based on reports of 15,494 people who have side effects when taking Incivek from the FDA, and is updated regularly.

What is Incivek?

Incivek has active ingredients of telaprevir. It is often used in hepatitis c. eHealthMe is studying from 15,526 Incivek users. Check the latest studies of Incivek.

What is Ascites?

Ascites (accumulation of fluid in the abdominal cavity) is found to be associated with 1,532 drugs and 2,029 conditions by eHealthMe. Check the latest studies of Ascites.

On Aug, 08, 2026

15,494 people reported to have side effects when taking Incivek.
Among them, 65 people (0.42%) have Ascites.

Among these 65 people:

How long have people been on Incivek when they have Ascites? *

What is the gender of people who have Ascites when taking Incivek? *

female: 49.18 %
male: 50.82 %

What is the age of people who have Ascites when taking Incivek? *

What are other drugs people take besides Incivek? *

What are other side effects people have besides Ascites? *

Thrombocytopenia (decrease of platelets in blood): 14 people, 21.54%
Acute Kidney Failure: 13 people, 20.00%
Anaemia (lack of blood): 13 people, 20.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 12 people, 18.46%
Abdominal Distension: 10 people, 15.38%
Hepatic Failure (liver failure): 9 people, 13.85%
Dyspnea (difficult or laboured breathing): 9 people, 13.85%
Haemoglobin Decreased: 8 people, 12.31%
Abdominal Pain: 7 people, 10.77%
Drug Ineffective: 7 people, 10.77%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 4.62%
Itching: 2 people, 3.08%
Gastric Disorder (disease of stomach): 2 people, 3.08%
Urination - Excessive Volume: 1 person, 1.54%
Type 2 Diabetes: 1 person, 1.54%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.54%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 1.54%
Insomnia (sleeplessness): 1 person, 1.54%
Immunodeficiency Disorders: 1 person, 1.54%
Cryoglobulinaemia (blood contains large amounts of cryoglobulins - proteins): 1 person, 1.54%

* Approximation only. Some reports may have incomplete information.

Do you take Incivek and have Ascites?

- Check whether Ascites is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Incivek:

Incivek (15,526 reports)

Ascites treatments and more:

Ascites (42,930 reports)

Browse all side effects of Incivek:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ascites:

Ascites (1,532 drugs)

Browse all the conditions that are associated with Ascites:

Ascites (2,029 conditions)

Related publications that referenced our studies

Rajsekhar P, Reddy MM, Vaddera S, Rajini G, Tikeli V, "A Rare Case of Vitamin B12 Deficiency with Ascites", Journal of clinical and diagnostic research: JCDR, 2014 Jan .
Rajsekhar P, Reddy MM, Vaddera S, Rajini G, Tikeli V, "A Rare Case of Vitamin B12 Deficiency with Ascites", Journal of clinical and diagnostic research: JCDR, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on telaprevir (the active ingredients of Incivek) and Incivek (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.